Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A benign disorder of tyrosine metabolism detected upon newborn screening and often observed in premature infants. It shows no clinical symptoms. It is characterized by tyrosinemia, moderate hyperphenylalaninemia, and tyrosiluria that usually resolve after 2 months of age.
No clinical trials have been registered for transient tyrosinemia of the newborn.
3 publications have been identified in PubMed for transient tyrosinemia of the newborn. Research spans Epidemiology / Natural History (67%) and Case Report / Case Series (33%).
Kahraman AB (2025). [PMID: 40466680](https://pubmed.ncbi.nlm.nih.gov/40466680/). *The Turkish journal of pediatrics*. [Epidemiology / Natural History]
Vallejo M (2025). [PMID: 40604926](https://pubmed.ncbi.nlm.nih.gov/40604926/). *Orphanet journal of rare diseases*. [Case Report / Case Series]
Gonçalves MM (2024). [PMID: 38535129](https://pubmed.ncbi.nlm.nih.gov/38535129/). *International journal of neonatal screening*. [Epidemiology / Natural History]
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 9:34 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center